National and sub-national prevalence, trend, and burden of cardiometabolic risk factors in iranian children and adolescents, 1990 - 2013

Archives of Iranian Medicine

Volumn 17, Issue 1, 2014, Pages 71-80

  Kelishadi, Roya ^a   Hovsepian, Silva ^a   Qorbani, Mostafa ^b,c   Jamshidi, Fahimeh ^a   Fallah, Zahra ^a   Djalalinia, Shirin ^b,d,e   Peykari, Niloofar ^b,d,e   Delavari, Alireza ^f   Farzadfar, Farshad ^b,d  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; Pediatrics; Prevalence; Risk factors

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; BAYES THEOREM; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHILD; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IRAN; OBESITY; PREVALENCE; RISK FACTOR; SOCIAL STATUS;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INFANT; IRAN; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84893080910     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2095-2128.
2. Dholpuria R, Raja S, Gupta BK. Atherosclerotic risk factors in adolescents. Indian J Pediatr. 2007; 74: 823-826.
3. Economic and social commission for Asia and the pacific. Emerging issues of health and mortality in the Asian and pacific region. New York; United Nations Publication. 2005; 155-156.
4. Couch SC, Cross AT, Kida K, Ros E, Plaza I, Shea S, et al. Rapid westernization of children's blood cholesterol in 3 countries: evidence for nutrient-gene interactions? Am J ClinNutr. 2000; 72: 1266S-1274S.
5. Antman EM, Selwyn AP, Braunwald E, et al. Ischemic heart disease. In: Fauci AS, Braunwald E, Kasper D, et al(eds). Harrison's Principle of Internal Medicine. 17th ed. New York, NY: McGraw-Hill. 2008; 1514-1526.
6. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years(DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2197-2223.
7. Vaiserman A. Early-life origin of adult disease: evidence from natural experiments. Exp Gerontol. 2011; 46: 189-192.
8. Johnson RC, Schoeni RF. Early-life origins of adult disease: national longitudinal population-based study of the United States. Am J Public Health.2011; 101: 2317-2324.
9. Russel P. The pathogenesis of artherosclerosis. In: Braunwald Heart disease. A textbook of cardiovasular disease, 6th Edition, 2001 W.B. Saunders Company; 1105-1106.
10. Prieto-Albino L, Arroyo Diez J, Vadillo Machota JM, Mateos Muntero C, Galan-Rebollo A. Prevalence of hyperlipidemia in children in the province of Caceres. Revista Espanola de saludpublica. 1998; 72: 343-355.
11. Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and adult cardiovascular disease risk: a systematic review. Int J Obes (Lond). 2010; 34:18-28.
12. Pitsavos C, Panagiotakos DB, Chrysohoou C, Stefanadis C. Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study. BMC Public Health. 2003; 3: 32.
13. Lobstein T, Jackson-Leach R. Estimated burden of pediatric obesity andco-morbiditiesin Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J PediatrObes. 2006; 1: 33-41.
14. Singh GM, Danaei G, Pelizzari PM, Lin JK, Cowan MJ, Stevens GA, et al. The age associations of blood pressure, cholesterol, and glucose: analysis of health examination surveys from international populations. Circulation. 2012; 125: 2204-2211.
15. Schwandt P, Kelishadi R, Haas GM. Ethnic disparities of the metabolic syndrome in population-based samples of German and Iranian adolescents. Metab Syndr Relat Disord. 2010; 8: 189-192.
16. Schwandt P, Kelishadi R, Ribeiro RQ, Haas GM, Poursafa P. A three-country study on the components of the metabolic syndrome in youths: the BIG Study. Int J Pediatr Obes. 2010; 5: 334-341.
17. Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W, Hasani MM, YusufaliAH, et al. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. Eur J Prev Cardiol. 2012.
18. Jones AC, Geneau R. Assessing research activity on priority interventions for non-communicable disease prevention in low-and middleincome countries: a bibliometric analysis. Glob Health Action. 2012; 5: 1-13.
19. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32: 1092-1097.
20. Kelishadi R, Alikhani S, Delavari A, Alaedini F, Safaie A, Hojatzadeh E. Obesity aad associated lifestyle behaviours in Iran: findings from the First National Non-communicable Disease Risk Factor Surveillance Survey. Public Health Nutr. 2008; 11: 246-251.
21. Esteghamati A, Khalilzadeh O, Mohammad K, Meysamie A, Rashidi A, Kamgar M, Et al. Secular trends of obesity in Iran between 1999and 2007: National Surveys of Risk Factors of Non-communicable Diseases. Metab Syndr Relat Disord. 2010; 8: 209-213.
22. Meysamie A, Ghaletaki R, Haghazali M, Asgari F, Rashidi A, KhalilzadehO, Et al. Pattern of tobacco use among the Iranian adult population: results of the national Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Tob Control. 2010; 19:125-128.
23. Kelishadi R, Gheiratmand R, Ardalan G, Adeli K, Mehdi Gouya M, Mohammad Razaghi E, MajdzadehR, et al. Association of anthropometric indices with cardiovascular disease risk factors among children and adolescents: CASPIAN Study. Int J Cardiol. 2007; 117: 340-348.
24. Kelishadi R, Ardalan G, Gheiratmand R, Ramezani A. Is family history of premature cardiovascular diseases appropriate for detection of dyslipidemic children in population-based preventive medicine programs? CASPIAN study. Pediatr Cardiol. 2006; 27: 729-736.
25. Kelishadi R, Ardalan G, Gheiratmand R, Majdzadeh R, Delavari A, Heshmat R, et al. Blood pressure and its influencing factors in a national representative sample of Iranian children and adolescents: the CASPIAN Study. Eur J Cardiovasc Prev Rehabil. 2006; 13: 956-963.
26. Kelishadi R, Pour MH, Sarraf-Zadegan N, Sadry GH, Ansari R, Alikhassy H, et al. Obesity and associated modifiable environmental factors in Iranian adolescents: Isfahan Healthy Heart Program-Heart Health Promotion from Childhood. Pediatr Int. 2003; 45: 435-442
27. Kelishadi R, Cook SR, Motlagh ME, Gouya MM, Ardalan G, MotaghianM, et al. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study. J Am Diet Assoc. 2008; 108: 82-90.
28. Kelishadi R, Ardalan G, Adeli K, Motaghian M, Majdzadeh R, Mahmood-ArabiMS, et al. Factor analysis of cardiovascular risk clustering in pediatric metabolic syndrome: CASPIAN study. Ann Nutr Metab. 2007; 51: 208-215.
29. Farzadfar F, Danaei G, Namdaritabar H, Rajaratnam JK, Marcus JR, Khosravi A, et al. National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr. 2011; 9: 55.
30. Farzadfar F, Delavari A, Malekzadeh R, Mesdaghinia A, Jamshidi HR, Sayyari A, et al. NASBOD 2013: Design, definitions, and metrics. Arch Iran Med. 2014; 17(1): 7-15.
31. Begg SJ, Vos T, Barker B, Stanley L, Lopez AD. Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust. 2008; 188: 36-40.
32. Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, BarqueraS, et al. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008; 5: e125.
33. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-RohaniH, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2224-2260.
34. Berenson GS, Wattigney WA, Bao W, Srinivasan SR, Radhakrishnamurthy B. Rationale to study the early natural history of heart disease: the Bogalusa Heart Study. Am J Med Sci. 1995; 31: S22-S28.
35. American Diabetes Association. Diagnosis and classification of diabetesmellitus. Diabetes Care. 2006; 29: S43-S48.
36. [Guideline] NHLBI. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114: 555-576.
37. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011; 128: S213-S256.
38. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004; 110: 2494-2497.
39. [Guideline] Task Force. Report of the Second Task Force on Blood Pressure Control in Children-1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics. 1987; 79: 1-25.
40. [Guideline] Task Force. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control. Pediatrics. 1996; 98: 649-658.
41. Motlagh ME, Kelishadi R, Ardalan G, Gheiratmand R, Majdzadeh R, Heidarzadeh A; CASPIAN Study Group. Rationale, methods and first results of the Iranian national programme for prevention of chronic diseases from childhood: CASPIAN Study. East Mediterr Health J. 2009; 15: 302-314.
42. Kelishadi R, Ardalan G, Gheiratmand R, Gouya MM, Razaghi EM, Delavari A, et al. CASPIAN Study Group. Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN Study. Bull World Health Organ. 2007; 85:19-26.
43. Mirkhani A, Motlagh ME, SedaghatM. Health status of Iranian students according to the health-risk behaviors survey 2006-2007. Publications of the Ministry of Health and Medical Education, Tehran, Iran.
44. Kelishadi R, Heshmat R, Motlagh ME, Majdzadeh R, Keramatian K, Qorbani M, et al. Methodology and Early Findings of the Third Survey of CASPIAN Study: A National School-based Surveillance of Students' High Risk Behaviors. Int J Prev Med. 2012; 3: 394-401
45. Kelishadi R, Majdzadeh R, Motlagh ME, Heshmat R, Aminaee T, Ardalan G, et al. Development and Evaluation of a Questionnaire for Assessment of Determinants of Weight Disorders among Children and Adolescents: The Caspian-IV Study. Int J Prev Med. 2012; 3: 699-705.
46. Kelishadi R, Ardalan G, Qorbani M, Ataie-Jafari A, Bahreynian M, Taslimi M, et al. Methodology and Early Findings of the Fourth Survey of Childhood and Adolescence Surveillance and Prevention of Adult Non-Communicable Disease in Iran: The CASPIAN-IV Study. Int J Prev Med. 2013; 4(12): 1451-1460.
47. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009; 9:167.
48. Azizi F, Madjid M, Rahmani M, Emami H, Mirmiran P, Hadjipour R. Tehran Lipid and Glucose Study (TLGS): rationale and design. Iran J Endoc and Met. 2000; 2: 77-86.
49. Azizi F, Ghanbarian A, Hadaegh F, Momenan AA, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study Phase II (Rationale & Study Design). Trials. 2009; 10: 5.
50. Parsaeian M, Farzadfar F, Zeraati H, Mahmoudi M, Rahimighazikalayeh G, Navidi I, et al. Application of spatio-temporal model to estimate burden of disease, injuries and risk factors in Iran 1990-2013. Arch Iran Med. 2014; 17(1): 28-33.
51. Kasaeian A, Eshraghian MR, Rahimi Foroushani A, Niakan Kalhori SR, Mohammad K, Farzadfar F. Bayesian autoregressive multilevel modeling of burden of diseases, injuries and risk factors in Iran 1990-2013. Arch Iran Med. 2014; 17(1): 22-27.
52. Motlagh ME, Kelishadi R, Amirkhani MA, Ziaoddini H, Dashti M, AminaeeT, et al. Double burden of nutritional disorders in young Iranian children: findings of a nationwide screening survey. Public Health Nutr. 2011; 14: 605-610.
53. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971; 49: 509-538.
54. Michael Gaziano J. Fifth Phase of the Epidemiologic Transition: The Age of Obesity and Inactivity. JAMA. 2010; 303: 275-276.
55. Prentice AM. Early influences on human energy regulation: Thrifty genotypes and thrifty phenotypes. Physiol Behav. 2005; 86: 640-645.
56. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev. 2007; 29: 62-76.
57. Sarrafzadegan N, Kelishadi R, Sadri G, Malekafzali H, Pourmoghaddas M, Heidari K, et al. Outcomes of a comprehensive healthy lifestyle program on cardiometabolic risk factors in a developing country: the Isfahan Healthy Heart Program. Arch Iran Med. 2013; 16: 4-11.
58. Sepanlou SG, Poustchi H, Kamangar F, Malekzadeh R. Effectiveness and feasibility of lifestyle and low-cost pharmacologic interventions in the prevention of chronic diseases: a review. Arch Iran Med. 2011; 14: 46-53.
59. Puska P. Community-based cardiovascular prevention programs: theory and practice. Arch Iran Med. 2013; 16: 2-3.
60. Capra L, Tezza G, Mazzei F, Boner AL. The origins of health and disease: the influence of maternal diseases and lifestyle during gestation. Ital J Pediatr.2013; 39: 7.
61. Hamidi A, Fakhrzadeh H, Moayyeri A, Pourebrahim R, Heshmat R, Noori M, et al. Obesity and associated cardiovascular risk factors in Iranian children: a cross-sectional study. Pediatr Int. 2006; 48: 566-571.
62. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventiv Med. 2002; 47: 408-426.
63. Asgari F, Aghajani H, Haghazali M, Heidarian H. Non-communicable diseases risk factors surveillance in Iran. Iran J Public Health. 2009; 38(suppl 1):119-122.
64. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005; 366:1640-1649.